Use of ubenimex for treating myelodysplastic syndrome

Details Use of ubenimex for treating myelodysplastic syndrome Use of ubenimex for treating myelodysplastic syndrome

1990-01-10

1990-10-16

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

A61K 31195

Patent

active

049635883

ABSTRACT:
This invention relates to a use of ubenimex or a pharmacologically acceptable salt thereof for treating myelodysplastic syndrome (MDS).

REFERENCES:
patent: 4189604 (1980-02-01), Umezawa et al.
patent: 4281180 (1981-07-01), Umezawa et al.
"Cancer Chemotherapy," vol. 7, pp. 76-82, Elsevier, Amsterdam (1985).
"Recent Results of Bestatin 1985--A Biological Response Modifier-," pp. 1-12, Japan Antibiotics Research Association, Tokyo (1985).

Affiliated with

Also associated with

Rating

Use of ubenimex for treating myelodysplastic syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of ubenimex for treating myelodysplastic syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ubenimex for treating myelodysplastic syndrome will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-850231